Увійти

Готові списки джерел за темами / Pulmonary surfactant / Дисертації

Щоб переглянути інші типи публікацій з цієї теми, перейдіть за посиланням: Pulmonary surfactant.

Дисертації з теми "Pulmonary surfactant"

Автор: Grafiati

Опубліковано: 4 червня 2021

Оновлено: 25 липня 2025

Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями

Оберіть тип джерела:

Ознайомтеся з топ-50 дисертацій для дослідження на тему "Pulmonary surfactant".

Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.

Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.

Переглядайте дисертації для різних дисциплін та оформлюйте правильно вашу бібліографію.

1

Lewis, R. W. "Pulmonary surfactant metabolism." Thesis, Cardiff University, 1985. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.332108.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

2

Hockey, Peter Morey. "Pulmonary surfactant and asthma." Thesis, University of Southampton, 2000. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.274434.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

3

Nilsson, Kristina. "Solute exchange across the alveolo-capillary barrier." Lund : Depts. of Clinical Physiology, Malmö University Hospital and Lund University Hospital, Lund University, 1997. http://books.google.com/books?id=A0hrAAAAMAAJ.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

4

Mo, Young Keun. "Surfactant proteins in extra pulmonary sites /." [St. Lucia, Qld.], 2005. http://www.library.uq.edu.au/pdfserve.php?image=thesisabs/absthe19083.pdf.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

5

Sullivan, Lucy Catherine. "The molecular evolution of vertebrate pulmonary surfactant /." Title page, summary and introduction only, 1996. http://web4.library.adelaide.edu.au/theses/09SB/09sbs949.pdf.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

6

Worthman, Lynn-Ann D. "Surfactant protein A (SP-A) affects pulmonary surfactant morphology and biophysical properties." Thesis, National Library of Canada = Bibliothèque nationale du Canada, 1997. http://www.collectionscanada.ca/obj/s4/f2/dsk2/tape16/PQDD_0014/MQ34241.pdf.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

7

Wood, Philip. "Control of pulmonary surfactant secretion : an evolutionary perspective /." Title page, table of contents and abstract only, 1999. http://web4.library.adelaide.edu.au/theses/09PH/09phw878.pdf.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

8

Mander, Ann. "Pulmonary surfactant and neutrophil function in cystic fibrosis." Thesis, University of Southampton, 1999. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.310701.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

9

McCarty, Kenneth Dean. "Characterization of pulmonary surfactant apoproteins in the diabetic mouse." CSUSB ScholarWorks, 1989. https://scholarworks.lib.csusb.edu/etd-project/512.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

10

Espinosa, Frank F. (Frank Francis). "Exogenous surfactant transport through the pulmonary airways : improving surfactant replacement therapy for neonatal respiratory distress syndrome." Thesis, Massachusetts Institute of Technology, 1996. http://hdl.handle.net/1721.1/10974.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

11

Zaltash, Shahparak. "Pulmonary surfactant proteins B and C : molecular organisation and involvement in respiratory disease /." Stockholm, 2000. http://diss.kib.ki.se/2000/91-628-4571-3/.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

12

Johnston, Sonya D. "Development of the pulmonary surfactant system in non-mammalian amniotes /." Title page, contents and abstract only, 2001. http://web4.library.adelaide.edu.au/theses/09PH/09phj737.pdf.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

13

Ocampo, Minette C. "Protein-Lipid Interactions with Pulmonary Surfactant Using Atomic Force Microscopy." The Ohio State University, 2014. http://rave.ohiolink.edu/etdc/view?acc_num=osu1395050693.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

14

Van, Houtte Paul. "Etude expérimentale de l'effet des irradiations et des agents chimiothérapiques sur le poumon et le métabolisme du surfactant." Doctoral thesis, Universite Libre de Bruxelles, 1985. http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/241286.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

15

Patel, Anjana. "Recombinant synthesis of pulmonary surfactant proteins SP-B and SP-C." Thesis, Aston University, 2018. http://publications.aston.ac.uk/37638/.

Повний текст джерела

Анотація:

SP-B and SP-C are two pulmonary surfactant proteins. They were isolated in the tear film in 2006 (Lukovic et al. 2006). The molecular mechanism governing lipid spreading in the tear film is not well understood and, along with their production in yeast (as an alternative to animal derived material) provide the motives for this research. To investigate the involvement of SP-B and SP-C in lipid spreading, SP-B and SP-C have been produced as recombinant proteins in Pichia pastoris yeast. SP-B and SP-C are cleaved from their proproteins to produce mature active proteins and both forms were produced

Стилі APA, Harvard, Vancouver, ISO та ін.

16

Dodd, Claire Elizabeth. "Impact of Pulmonary Surfactant on Human Macrophage Susceptibility to Mycobacterium tuberculosis." The Ohio State University, 2017. http://rave.ohiolink.edu/etdc/view?acc_num=osu1491747880967301.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

17

Cai, Jingfei. "Probing the Membrane Association Mechanisms for Pulmonary Collectins and Mammalian Phospholipase C." Thesis, Boston College, 2013. http://hdl.handle.net/2345/3872.

Повний текст джерела

Анотація:

Thesis advisor: Mary F. Roberts<br>Thesis advisor: Eranthie Weerapana<br>Peripheral proteins from mammals often exhibit multi-domain structures and require metal ions such as calcium as co-factors. This dissertation investigates two types of such proteins -- pulmonary collectins (surfactant proteins A and D) and phosphatidylinositol-specific phospholipase C (PLC) delta1 -- and their interactions with model membranes. One approach to work around the complexity brought upon by such multi-domain protein structure is to use a truncated construct or an isolated single domain. For pulmonary collecti

Стилі APA, Harvard, Vancouver, ISO та ін.

18

Rova, M. (Meri). "The significance of surfactant protein gene polymorphisms in multifactorial infantile pulmonary diseases." Doctoral thesis, University of Oulu, 2005. http://urn.fi/urn:isbn:9514277481.

Повний текст джерела

Анотація:

Abstract Pulmonary surfactant is a lipid-protein mixture that lines the inner surface of the lung. The main function of surfactant is to reduce surface tension at the air-liquid interface, thus preventing alveolar collapse at the end of expiration. Lack of surfactant is the main cause of respiratory distress syndrome (RDS) in preterm infants. Very preterm babies are at risk of developing a lung disease called bronchopulmonary dysplasia (BPD). The surfactant proteins SP-A, -B, -C and -D have important functions in surfactant structure, homeostasis and innate immunity of the lung. The genes of t

Стилі APA, Harvard, Vancouver, ISO та ін.

19

Sallese, Anthony. "Elucidating the Pathogenesis of Pulmonary Alveolar Proteinosis." University of Cincinnati / OhioLINK, 2017. http://rave.ohiolink.edu/etdc/view?acc_num=ucin1491813093586635.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

20

Li, Jing. "Processing, stability and interactions of lung surfactant protein C /." Stockholm, 2005. http://diss.kib.ki.se/2005/91-7140-582-8/.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

21

Kazemi, Taskooh Alireza. "Transport of complex fluids in the human pulmonary airway system." Thesis, Université Paris-Saclay (ComUE), 2019. http://www.theses.fr/2019SACLX077/document.

Повний текст джерела

Анотація:

La Thérapie par Substitution de Surfactant (TSS), qui opère par instillation d’une solution de surfactant directement dans l’arbre bronchique, est un traitement essentiel chez les nouveau-nés souffrant de syndrome de détresse respiratoire (SDRN). Cette procédure s’est révélée remarquablement efficace chez les grands prématurés, contribuant à la division par cinq de leur mortalité depuis les années 1980. À l’inverse, son utilisation s’est avérée décevante chez l’adulte dans le traitement du syndrome de détresse respiratoire aigu (SDRA), se soldant par un échec après des premiers essais pourtant

Стилі APA, Harvard, Vancouver, ISO та ін.

22

Miller, Natalie J. "The evolution of a physiological system the pulmonary surfactant system in diving mammals /." Connect to this title online, 2005. http://hdl.handle.net/2440/37717.

Повний текст джерела

Анотація:

Pulmonary surfactant is a complex mixture of lipids and proteins that lowers surface tension, increases lung compliance, and prevents the adhesion of respiratory surfaces and pulmonary oedema. Pressure can have an enormous impact on respiratory function, by mechanically compressing tissues, increasing gas tension resulting in increased gas absorption and by increasing dissolved gas tensions during diving, resulting in the formation of bubbles in the blood and tissues. The lungs of diving mammals have a huge range of morphological adaptations to enable them to endure the extremely high pressure

Стилі APA, Harvard, Vancouver, ISO та ін.

23

Aydın, Evrim Kaya Hakan. "Gebe koyunlara intraamniyotik surfaktan uygulamasının preterm kuzuların akciğer gelişimi üzerine etkilerinin histopatolojik ve biyokimyasal olarak değerlendirilmesi /." Isparta : SDÜ Tıp Fakültesi, 2005. http://tez.sdu.edu.tr/Tezler/TT00186.pdf.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

24

O'Toole, Stuart John. "The pulmonary surfactant system in congenital diaphragmatic hernia and the influence of fetal surgery on its development." Thesis, University of Newcastle Upon Tyne, 2000. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.312035.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

25

Wood, Philip. "Functional significance and control of release of pulmonary surfactant in the lizard lung /." Title page and abstract only, 1994. http://web4.library.adelaide.edu.au/theses/09SB/09sbw878.pdf.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

26

Al-Gawhari, Fatima Jalal. "Development of a non-ionic surfactant vesicles formulation of gemcitabine for pulmonary delivery." Thesis, University of Strathclyde, 2013. http://oleg.lib.strath.ac.uk:80/R/?func=dbin-jump-full&object_id=22647.

Повний текст джерела

Анотація:

Lung cancer is a major cause of death in the world. Cancer chemotherapy is limited by adverse toxicities to normal tissues. Targeted delivery of anticancer drugs to lung cancer by inhalation would help to reduce these toxicities. Lipid based delivery systems have been shown to be effective in improving the delivery of a number of drugs and the potential of using non-ionic surfactant vesicles (NIV) to improve the delivery of Gemcitabine (Gem) was studied in this project. NIV were used to encapsulate Gem (Gem-NIV) for delivery by the pulmonary route. NIV were prepared using different concentrati

Стилі APA, Harvard, Vancouver, ISO та ін.

27

Codd, Jonathan Richard. "Torpor associated fluctuations in the pulmonary surfactant system in Gould's wattled bat Chalinolobus Gouldii /." Title page, contents and abstract only, 2001. http://web4.library.adelaide.edu.au/theses/09SM/09smc669.pdf.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

28

Henning, Lisa Novik. "Pulmonary surfactant protein a regulation of macrophage toll-like receptor expression, activity, and trafficking /." Columbus, Ohio : Ohio State University, 2008. http://rave.ohiolink.edu/etdc/view?acc%5Fnum=osu1211479279.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

29

Nag, Kaushik. "Association and interactions of pulmonary surfactant lipids and proteins in model membranes at the air-water interface." Thesis, National Library of Canada = Bibliothèque nationale du Canada, 1996. http://www.collectionscanada.ca/obj/s4/f2/dsk3/ftp04/NQ56665.pdf.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

30

Bohlin, Kajsa. "Surfactant metabolism in the newborn : the impact of ventilation strategy and lung disease /." Stockholm : Karolinska institutet, 2005. http://diss.kib.ki.se/2005/91-7140-229-2/.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

31

Beresford, Michael William. "The role of pulmonary surfactant proteins and inflammatory cytokines in preterm infants ventilated for respiratory distress receiving natural or synthetic surfactant therapies." Thesis, University of Liverpool, 2002. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.268903.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

32

Carlson, Tracy Karin. "The Effects of Pulmonary Surfactant Protein-D on Innate Immune Cells and Tuberculosis Pathogenesis." The Ohio State University, 2011. http://rave.ohiolink.edu/etdc/view?acc_num=osu1299708141.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

33

Kerr, Margaret Heather. "An investigation of the pulmonary surfactant system in children with severe respiratory syncytial virus infection." Thesis, University of Glasgow, 1998. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.265640.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

34

Spitler, Grant. "In vitro dissolution of uranium contaminated soil in simulated lung fluid containing a pulmonary surfactant." University of Cincinnati / OhioLINK, 2013. http://rave.ohiolink.edu/etdc/view?acc_num=ucin1377871194.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

35

Liu, Pamela Siumey. "Resposta imune induzida em camundongos por imunização transcutânea com proteína recombinante LipL32 de leptospira." Universidade de São Paulo, 2016. http://www.teses.usp.br/teses/disponiveis/87/87131/tde-24082016-100639/.

Повний текст джерела

Анотація:

A imunização transcutânea (TCI) é uma via atrativa para o desenvolvimento de vacinação livre de agulhas, atuando nas APCs da pele, podendo substituir algumas das imunizações convencionais, em termos de facilidade, segurança e eficácia. O presente estudo avaliou a resposta imune da TCI com proteína recombinante de leptospira LipL32, uma proteína altamente conservada em cepas patogênicas e potente candidata vacinal. A TCI com a LipL32 na região abdominal de C57BL-6 foi capaz de primar o sistema imune, suscitando resposta sistêmica com altos níveis de anticorpos contra o antígeno, após reforços s

Стилі APA, Harvard, Vancouver, ISO та ін.

36

Bulek, Anna Marta. "Effect of pulmonary surfactant on innate immune responses in influenza virus infected human airway epithelial cells." Thesis, Cardiff University, 2008. http://orca.cf.ac.uk/55755/.

Повний текст джерела

Анотація:

Overwhelming inflammatory responses leading to neutrophil invasion are hypothesised to be the main cause of mortality in influenza virus induced acute respiratory distress syndrome (ARDS). Previously, pulmonary surfactant has been shown to modulate inflammatory responses to bacterial agents. The aim of the present study was to investigate the effect of pulmonary surfactant on innate immune responses in an in vitro model of influenza virus infected human airway epithelial cells. Human lung type II alveolar epithelial cells A549 and BEAS-2B human bronchial epithelial cells were infected with inf

Стилі APA, Harvard, Vancouver, ISO та ін.

37

Munteanu, Bogdan. "Actions de particules d’usure aéroportées sur les propriétés mécaniques et physicochimiques des «films» de surfactant pulmonaire : Conséquences sur la conception de particules tribo-bio-compatibles." Thesis, Lyon, INSA, 2015. http://www.theses.fr/2015ISAL0034/document.

Повний текст джерела

Анотація:

Paradoxalement, la sécurité routière est assurée entre autre par la production de particules d’usure ! Ainsi, près de 20 000 tonnes de garnitures de frein sont usées par an en France, dont 9 000 tonnes sous forme de particules d’usure aéroportées. Ces particules posent des problèmes de santé car leur composition chimique et leur morphologie font qu’elles interagissent avec la paroi alvéolaire entrainant des pathologies. Au cours de ces pathologies la phase la plus étudiée est la phase inflammatoire qui s’installe une fois que la particule a passé la première barrière de protection qui est le f

Стилі APA, Harvard, Vancouver, ISO та ін.

38

Maker, Garth Lucas. "Regulation of surfactant production by fetal type II pneumocytes and characterization of fibroblast-pneumocyte factor /." Access via Murdoch University Digital Theses Project, 2007. http://wwwlib.murdoch.edu.au/adt/browse/view/adt-MU20080430.141113.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

39

Lindwall, Robert B. I. "Respiratory distress syndrome : aspects of inhaled nitric oxide surfactant and nasal CPAP /." Stockholm, 2005. http://diss.kib.ki.se/2005/91-7140-297-7/.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

40

Frangolias, Despina Daisy. "Candidate genes other than the CFTR gene as possible modifiers of pulmonary disease severity in cystic fibrosis." Thesis, University of British Columbia, 2008. http://hdl.handle.net/2429/527.

Повний текст джерела

Анотація:

Cystic fibrosis (CF) is a single gene Mendelian disorder characterized by pulmonary disease and pancreatic insufficiency. Pulmonary disease is the major cause of death in CF patients. Although some cystic fibrosis transmembrane conductance regulator (CFTR) genotypes are associated with less severe disease, patients possessing the same genotype show great variation in pulmonary disease severity and progression. Genes involved in modulating the inflammatory response and genes increasing susceptibility to infection are proposed as modifiers of pulmonary disease severity. Polymorphisms selected f

Стилі APA, Harvard, Vancouver, ISO та ін.

41

Langman, Carly. "Thermal influences upon the composition and function of pulmonary surfactant in a heterothermic mammal [sic] (Sminthopsis crassicaudata) /." Adelaide, 1995. http://web4.library.adelaide.edu.au/theses/09S.B/09s.bl284.pdf.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

42

Deb, Roona. "An investigation of the roles of lung surfactant proteins -A and -D in the pulmonary allergic response." Thesis, University of Oxford, 2006. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.440148.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

43

Fisher, Carolyn E. "Fibres in vitro : the importance of pulmonary surfactant, tumour necrosis factor alpha, nitric oxide and ferric iron." Thesis, Edinburgh Napier University, 1999. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.285698.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

44

Souza, João Francisco Ventrici de. "Efeito de materiais particulados em sistemas modelos de biomembranas." Universidade de São Paulo, 2012. http://www.teses.usp.br/teses/disponiveis/59/59138/tde-13042012-144908/.

Повний текст джерела

Анотація:

Neste trabalho foram estudadas algumas propriedades de sistemas miméticos de tensoativos pulmonares (TP) constituídos de dipalmitoilfosfatidilcolina (DPPC) e DPPC/colesterol e suas interações com o material particulado (MP) proveniente da queima da palha da cana-de-açúcar, reconhecido por meio de estudos clínicos como agente agravador de diversas patologias respiratórias. O MP utilizado neste trabalho foi analisado por meio de uma série de técnicas: espalhamento dinâmico de luz (DLS), microscopia eletrônica de varredura acrescida do uso de análise de energia dispersiva de raios X (MEV e MEV-ED

Стилі APA, Harvard, Vancouver, ISO та ін.

45

au, G. Maker@murdoch edu, and Garth Lucas Maker. "Regulation of surfactant production by fetal type II pneumocytes and the characterization of fibroblast-pneumocyte factor." Murdoch University, 2008. http://wwwlib.murdoch.edu.au/adt/browse/view/adt-MU20080430.141113.

Повний текст джерела

Анотація:

The fetal lung undergoes extensive physiological and biochemical maturation prior to birth in preparation for its postnatal function as an organ for gas exchange. Pulmonary surfactant, a substance that reduces surface tension and prevents alveolar collapse, is produced by type II pneumocytes within the lung. Reduced ability to produce surfactant leads to neonatal respiratory distress syndrome. Synthesis of the phospholipid component of surfactant, phosphatidylcholine (PC), is stimulated by fibroblast-pneumocyte factor (FPF), a protein expressed by fibroblast cells within the fetal lung. Althou

Стилі APA, Harvard, Vancouver, ISO та ін.

46

Väyrynen, O. (Outi). "Proinflammatory cytokines modify the expression of surfactant proteins:study in perinatal rabbit lung." Doctoral thesis, University of Oulu, 2003. http://urn.fi/urn:isbn:9514270584.

Повний текст джерела

Анотація:

Abstract Deficiency of pulmonary surfactant is the main cause of respiratory distress syndrome (RDS) in premature newborn infants, which is often complicated by chronic lung disease (CLD). Preterm birth is often associated with intra-amniotic infection (IUI), which is characterized by increased proinflammatory cytokines, such as interleukin-1 (IL-1) and tumor necrosis factor-α (TNF-α), in the amniotic fluid. In very preterm birth due to IUI, the incidence of RDS is decreased, while the incidence of CLD is increased. Maternal glucocorticoids are used in imminent preterm birth to prevent RDS. Th

Стилі APA, Harvard, Vancouver, ISO та ін.

47

Dico, Awel Seid. "A ²H-NMR study of interactions in model membranes containing pulmonary surfactant proteins SP-B and SP-C." Thesis, National Library of Canada = Bibliothèque nationale du Canada, 1998. http://www.collectionscanada.ca/obj/s4/f2/dsk2/ftp03/NQ34245.pdf.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

48

Smith, Johan. "A comparison of synthetic surfactants : evaluation of a novel surfactant (1,2-dipalmitoyl-sn-phosphatidycholine and trehalose [C12H22O11]) and comparison with other synthetic formulations." Thesis, Stellenbosch : Stellenbosch University, 2002. http://hdl.handle.net/10019.1/52624.

Повний текст джерела

Анотація:

In title 12, 22, 11 are in subscript.<br>Thesis (PhD)--Stellenbosch University, 2002.<br>ENGLISH ABSTRACT: The aim of this study was to test a synthetic protein-free surfactant preparation, LPM-l, with the same chemical composition as commercially available Exosurf (Glaxo Wellcome), but containing in addition, a sugar, trehalose (TRE). Towards this end, a study was designed to firstly test the hypothesis that the true difference in acute physiological effects between a mixture of oppe, tyloxapol, hexadecanol and trehalose (LPM-l), and Exosurf, (Oppe, tyloxapol and hexadecanol) is zero, i

Стилі APA, Harvard, Vancouver, ISO та ін.

49

Rausch, Felix [Verfasser], Ludger A. [Akademischer Betreuer] Wessjohann, and Harald [Akademischer Betreuer] Lanig. "3D modeling of the putative human surfactant proteins SP-G and SP-H and simulations in a pulmonary surfactant model system / Felix Rausch. Betreuer: Ludger A. Wessjohann ; Harald Lanig." Halle, Saale : Universitäts- und Landesbibliothek Sachsen-Anhalt, 2015. http://d-nb.info/107850511X/34.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

50

WAN, HUAJING. "CRITICAL ROLES OF FORKHEAD BOX A2 DURING LUNG DEVELOPMENT." University of Cincinnati / OhioLINK, 2004. http://rave.ohiolink.edu/etdc/view?acc_num=ucin1091650603.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Ми пропонуємо знижки на всі преміум-плани для авторів, чиї праці увійшли до тематичних добірок літератури. Зв'яжіться з нами, щоб отримати унікальний промокод!